GraphWear Technologies

GraphWear is a developer of needle-free continuous glucose monitoring wearable devices, which can diagnose diseases in sweat in real time, thereby revolutionizing healthcare. The company is advancing a non-invasive method to map patient health without the use of needles, blood, or urine. The company's disease management platform provides the possibility for clinical trials for its first target: monitoring blood glucose levels in diabetic patients, and has the potential to play a role in diseases such as heart disease and cancer.